RAISE, shared on LinkedIn:
“RAISE raises €100M for its second Invest in Medical Research sharing fund.
The RAISE Group announces the first closing of Investir pour la Recherche Médicale (IPRM), its second sharing fund, with a target size of €200 million, the objective of which is to share 50% of capital gains and 50% of management costs with four major medical research institutions.
This first round brings together AXA, Banque des Territoires, Crédit Agricole Assurances as co-lead as well as CARAC and Pierre Fabre Laboratories, driven by a common conviction:
Private equity can become a structural lever for financing major causes of general interest.
The beneficiaries of this scheme are four major institutions whose complementarity covers the entire medical research chain, from basic research to clinical innovation:
- Gustave Roussy: the first French and European cancer centre, the third in the world, and an international reference for all cancers at all ages of life;
- Institut Pasteur: a foundation recognized as being of public utility and a world-renowned biomedical research center. Its teams are committed to fighting diseases, in France and internationally, through their research, public health, teaching and scientific application development activities;
- Institut Imagine: the first European centre for research, care and teaching dedicated to genetic diseases, already a beneficiary of the Invest for Children sharing fund;
- Fondation pour la Recherche Médicale (FRM): the leading non-profit funder supporting all public medical research in France.
By mobilizing private equity mechanisms for research, IPRM intends to make a complementary and sustainable contribution to this collective effort.
Thank you to all our partners for their trust and commitment.”
Fabrice Barlesi, Chief Executive Officer at Gustave Roussy, added:
“Major support for research by Gustave Roussy, the 1st cancer center in Europe and 3rd in the world.
Today’s research is, and increasingly fast, tomorrow’s drugs and strategies for the 450,000 patients diagnosed each year and the 4 to 6 million women and men living with cancer.
Thank you to RAISE for being by our side in such a determined way.”
Gonzague de Blignières:
Since the establishment of RAISE, we have sought to demonstrate that the financial sector can mobilize around causes of public interest without compromising its performance standards. With our first profit-sharing fund, Investir pour l’Enfance, we demonstrated that this model worked. With Investir pour la Recherche Médicale, we are taking this model to a new scale and deploying it in support of a cause that concerns every one of us.
Co-founder of RAISE, Chairman of the Supervisory Board and of RAISE Sherpas
Eric de La Vigne:
It is the combination of performance, value sharing, and collective benefit that makes Investir pour la Recherche Médicale so distinctive.
Partner
Gilbert Chahine:
We are pleased to renew our confidence in RAISE through this second profit-sharing fund. With Investir pour la Recherche Médicale, we are supporting an innovative initiative dedicated to a cause of public interest as essential as medical research, with the aim of providing healthcare innovation stakeholders with the means to address the major health challenges of the future.
This ability to create value while sharing it for the benefit of society fully reflects our vision of responsible, long-term committed investment.
Chief Executive Officer of AXA Mutual Insurance Companies
François Wohrer:
Investir pour la Recherche Médicale is the seventh profit-sharing fund in which the Banque des Territoires has invested and the second alongside RAISE. This fund enables us to continue supporting major medical research stakeholders in France and to strengthen our support for the Pépinière d’Avenirs association, of which the Caisse des Dépôts is a founding member.
Director of Investment, Banque des Territoires
You may also be interested in:
Reed Jobs’ Yosemite Raises $350 Million to Support Cancer Research
Ali Zeaiter Brings 20 Years of Oncology Experience to Pierre Fabre
